SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-06
👔
PTC THERAPEUTICS, INC.
@PTCT_InsiderForm 4 Filing: Klein Matthew B. Sells $705,722.44 of $PTCT
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
PTC THERAPEUTICS, INC.
Ticker: $PTCT
Transaction Value
$705,722.44
Price/Share: $68.57
transaction date
2026-08-04
Shares: 10,292
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Klein Matthew B., holds the title of CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC..
On 2026-08-04, the insider transacted 10,292 shares.The shares were transacted at a weighted average price of $68.57 per share, resulting in a total market-relevant value of $705,722.44.
Executive Summary Summary
Klein Matthew B. (CHIEF EXECUTIVE OFFICER) sold $706K of $PTCT
Post-Transaction Position: 383,868 shares
SEC Accession No: 0001808968-26-000017 (CIK: 1808968)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.